Handa Pharmaceuticals, Inc. (6620)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
143. 50
+13
+9.9617%
NT$
- Market Cap
- P/E Ratio
20% Div Yield
5.41M Volume
- Eps
NT$ 130.5
Previous Close Want to track 6620 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Handa Pharmaceuticals, Inc. (6620) Statistics
Valuation metrics
Market Cap -
Enterprise value 19.78B
Trailing P/E (ttm) 41.4
Forward P/E -
PEG ratio -1.53
Price/Sales (ttm) 17.53
Price/Book (mrq) 4.13
Enterprise Value/Revenue 16.33
Enterprise Value/EBITDA 31.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.86M
Average volume (90 days) 2.25M
Price summary
52-Week low 64.1
52-Week high 155
Beta -
50-Day moving average 116.85
200-Day moving average 88.57
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.07
Trailing annual dividend yield 0.0163%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Jul 2026
Ex-Dividend Date 6 Jul 2026
Last split factor 203:200
Last split Date 8 Jun 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.4%
Operating margin 0.37%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 22.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.97%
Book value per share (mrq) 30.9
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
